润都股份：关于缬沙坦氨氯地平片（I）获得药品注册证书的公告

Core Viewpoint - The company, Rundu Co., has received a drug registration certificate from the National Medical Products Administration for its product, Valsartan Amlodipine Tablets (I) [2] Company Summary - Rundu Co. announced the receipt of the drug registration certificate on the evening of September 29 [2] - The registered drug is Valsartan Amlodipine Tablets (I), indicating a new product introduction in the pharmaceutical market [2] Industry Summary - The approval of Valsartan Amlodipine Tablets (I) reflects ongoing regulatory support for new drug registrations in the pharmaceutical industry [2] - This development may enhance the competitive landscape within the cardiovascular drug segment [2]